tiprankstipranks
Trending News
More News >
Ecolab Inc (ECL)
NYSE:ECL

Ecolab (ECL) AI Stock Analysis

Compare
1,385 Followers

Top Page

EC

Ecolab

(NYSE:ECL)

Rating:77Outperform
Price Target:
Ecolab demonstrates a robust position in the Chemicals - Specialty industry with strong financial performance driven by consistent revenue growth and effective cost management. Despite the high valuation limiting upside potential, the company's strategic investments in digital technologies and growth initiatives, as well as positive market momentum, support a promising outlook. Challenges in the global trade environment and increased costs due to tariffs present risks, but the overall growth trajectory remains favorable.
Positive Factors
Digital Technology Integration
The integration of digital technology enhances customer experience and addresses labor shortage issues, with digital programs expected to eventually exceed more than $1 billion in revenue.
New Business Wins
New business wins during the quarter were strong and broad-based, which is helping offset pockets of weakness.
Strategic Investments
The company continues to invest for long-term growth in strategic categories like life sciences, pest intelligence, global high tech water, and Ecolab digital, all of which should continue to drive operating margins toward management’s 20% target by 2027.
Negative Factors
Soft End-Markets
End-markets remain soft keeping volumes suppressed.
Tariff Impact
Tariffs pose risks impacting 10% of its raw materials from other geographies.
Water Segment Concerns
There is investor concern about softer-than-expected organic growth in the Water segment and a fear that a tariff-related price hike might be reactionary.

Ecolab (ECL) vs. SPDR S&P 500 ETF (SPY)

Ecolab Business Overview & Revenue Model

Company DescriptionEcolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences segments. The Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, pulp and paper, commercial laundry, petroleum, refining, and petrochemical industries. The Global Institutional & Specialty segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education, and retail industries. Its Global Healthcare & Life Sciences segment offers specialized cleaning and sanitizing products to the healthcare, personal care, and pharmaceutical industries, such as infection prevention and surgical solutions, and end-to-end cleaning and contamination control solutions under the Ecolab, Microtek, and Anios brand names. The company's Other segment offers pest elimination services to detect, eliminate, and prevent pests, such as rodents and insects in restaurants, food and beverage processors, educational and healthcare facilities, hotels, quick service restaurant and grocery operations, and other institutional and commercial customers. This segment also provides colloidal silica for binding and polishing applications in semiconductor, catalyst, and aerospace component manufacturing, as well as chemical industries; and products and services that manage wash process through custom designed programs, premium products, dispensing equipment, water and energy management, and reduction, as well as real time data management. It sells its products through field sales and corporate account personnel, distributors, and dealers. The company was founded in 1923 and is headquartered in Saint Paul, Minnesota.
How the Company Makes MoneyEcolab makes money through a diversified revenue model that includes the sale of products, equipment, and services across its various sectors. Key revenue streams include its Global Industrial, Global Institutional, and Global Healthcare & Life Sciences divisions. The company generates revenue by providing customized solutions tailored to the specific needs of each sector, often through long-term contracts and service agreements. Significant partnerships with industries such as food and beverage processing, healthcare facilities, and hospitality companies further enhance its revenue potential. Ecolab's ability to drive growth is supported by its focus on innovation, sustainability, and efficiency improvements, which attract and retain a broad customer base.

Ecolab Key Performance Indicators (KPIs)

Any
Any
Revenue by Segment
Revenue by Segment
Breaks down sales across various business areas, indicating which segments are performing well and contributing most to overall revenue growth.
Chart InsightsEcolab's Industrial segment shows strong growth momentum, driven by strategic initiatives despite global trade challenges and industrial market softness. The Institutional and Specialty segment also maintains robust growth, benefiting from the One Ecolab strategy. However, the Healthcare and Lifesciences segment faces volatility, potentially due to increased tariffs and global trade complexities. The earnings call highlights Ecolab's focus on digital and Life Sciences growth, which could mitigate some of these pressures, while the 5% trade surcharge aims to offset rising costs.
Data provided by:Main Street Data

Ecolab Earnings Call Summary

Earnings Call Date:Apr 29, 2025
(Q1-2025)
|
% Change Since: 11.67%|
Next Earnings Date:Aug 05, 2025
Earnings Call Sentiment Neutral
Ecolab showcased strong earnings growth, margin improvement, and success in the Life Sciences and digital segments. However, challenges in the global trade environment, industrial market softness, and increased costs due to tariffs present notable concerns.
Q1-2025 Updates
Positive Updates
Strong Earnings Growth
Ecolab experienced a strong quarter with double-digit earnings growth, including 3% organic sales growth and 12% EPS growth, outpacing the software markets.
Operating Income Margin Improvement
The company achieved a 190 basis point increase in operating income margin, aiming for a 20% operating income margin by 2027.
Life Sciences Segment Success
Life Sciences grew organic sales mid-single-digits with over 30% growth in organic operating income, driven by double-digit growth in the biopharma business.
Robust Free Cash Flow
Ecolab reported strong and resilient free cash flow, with a healthy balance sheet, over $1 billion in cash, and a 1.8x net debt to adjusted EBITDA ratio.
Ecolab Digital Growth
Ecolab Digital sales grew 12% to $80 million in the first quarter, with expectations for acceleration throughout the year, driven by strong growth in subscription revenue.
Negative Updates
Global Trade Environment Concerns
Ecolab faces challenges from a rapidly changing global trade environment, including a 10% global baseline tariff and a 145% tariff on China, impacting costs.
Industrial Market Softness
There is a noted softness in demand, particularly in heavy industrial markets, with expectations for continued softness throughout the year.
Increased Costs Due to Tariffs
The tariffs have resulted in increased costs for raw materials, packaging, and some equipment, with an anticipated impact of a few hundred million dollars annually.
Pest Elimination Challenges
Pest Elimination segment faced safety issues negatively impacting profitability, though improvement is expected in the second quarter.
Company Guidance
In the Ecolab First Quarter 2025 earnings call, the company reported strong financial performance with double-digit earnings growth, attributed to a 3% increase in organic sales and a 12% rise in earnings per share (EPS). Ecolab also achieved a 190 basis point improvement in operating income margin, progressing towards a 20% margin goal by 2027. Despite facing challenges such as a complex global operating environment and increased tariffs, Ecolab announced a 5% trade surcharge for U.S. customers to offset these costs. The company is focused on growth initiatives, including the One Ecolab strategy, which has delivered significant market share gains. Ecolab's investments in digital technologies like Ecolab Digital, which saw sales grow 12% to $80 million in the first quarter, and other growth engines like Life Sciences and Pest Intelligence, are also expected to fuel future sales growth and margin expansion.

Ecolab Financial Statement Overview

Summary
Ecolab showcases a strong financial performance, driven by consistent revenue growth and robust profitability margins. The balance sheet reflects a stable capital structure with manageable leverage, while the cash flow position underscores efficient cash generation capabilities. Despite some fluctuations in free cash flow, the overall outlook remains positive, supported by strategic investments and effective cost management.
Income Statement
85
Very Positive
Ecolab's income statement reflects strong profitability with a consistent increase in gross profit margin from 41.4% in 2020 to 43.7% in TTM 2025. The net profit margin has also improved, reaching 13.4% in TTM 2025, indicating efficient cost management. Revenue growth has been steady, with a notable 21.0% increase from 2020 to 2021 and continued growth across subsequent years, though slightly declining in TTM 2025. EBIT and EBITDA margins have shown robust performance, reflecting operational efficiency. Overall, Ecolab demonstrates solid revenue growth and profitability metrics.
Balance Sheet
78
Positive
Ecolab's balance sheet shows a stable financial position with a debt-to-equity ratio of 0.93 in TTM 2025, highlighting moderate leverage. The return on equity has improved from 15.9% in 2020 to 23.7% in TTM 2025, indicating effective use of shareholder equity. The equity ratio remains reasonable at 39.7%, suggesting a balanced capital structure. However, the company's total debt level, while stable, remains significant, which could pose a risk in adverse economic conditions.
Cash Flow
82
Very Positive
Ecolab's cash flow statement reveals a healthy free cash flow generation, with a growth rate of 27.5% from 2022 to TTM 2025. The operating cash flow to net income ratio is strong at 1.03 in TTM 2025, indicating solid cash generation relative to net income. However, the decline in free cash flow from 2024 to TTM 2025 suggests potential volatility in cash flow despite overall positive performance. The company maintains a focus on capital investments, supporting future growth.
Breakdown
TTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
15.68B15.74B15.32B14.19B12.73B11.79B
Gross Profit
6.86B6.84B6.19B5.36B5.12B4.88B
EBIT
2.86B2.80B1.99B788.80M892.00M818.50M
EBITDA
3.89B3.85B3.03B2.79B2.71B2.50B
Net Income Common Stockholders
2.10B2.11B1.37B1.09B1.13B984.80M
Balance SheetCash, Cash Equivalents and Short-Term Investments
598.60M1.26B919.50M598.60M359.90M1.26B
Total Assets
21.46B22.39B21.85B21.46B21.21B18.13B
Total Debt
9.03B8.28B8.73B8.92B9.04B6.99B
Net Debt
8.43B7.03B7.81B8.32B8.68B5.73B
Total Liabilities
14.21B13.60B13.77B14.21B13.95B11.92B
Stockholders Equity
7.24B8.76B8.04B7.24B7.22B6.17B
Cash FlowFree Cash Flow
1.37B1.82B1.64B1.08B1.42B1.37B
Operating Cash Flow
2.16B2.81B2.41B1.79B2.06B1.86B
Investing Cash Flow
-232.80M-433.80M-990.50M-716.80M-4.58B-414.50M
Financing Cash Flow
-1.13B-2.02B-1.05B-837.30M1.60B-341.80M

Ecolab Technical Analysis

Technical Analysis Sentiment
Positive
Last Price266.93
Price Trends
50DMA
250.28
Positive
100DMA
252.11
Positive
200DMA
249.38
Positive
Market Momentum
MACD
4.61
Negative
RSI
66.40
Neutral
STOCH
89.23
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ECL, the sentiment is Positive. The current price of 266.93 is above the 20-day moving average (MA) of 260.27, above the 50-day MA of 250.28, and above the 200-day MA of 249.38, indicating a bullish trend. The MACD of 4.61 indicates Negative momentum. The RSI at 66.40 is Neutral, neither overbought nor oversold. The STOCH value of 89.23 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ECL.

Ecolab Risk Analysis

Ecolab disclosed 23 risk factors in its most recent earnings report. Ecolab reported the most risks in the “Legal & Regulatory” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 1 New Risks
1.
Our increasing reliance on artificial intelligence ("AI") technologies in our products, services, and operations presents several risks that could adversely impact our business, financial condition, and results of operations. Q4, 2024

Ecolab Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
SHSHW
78
Outperform
$89.65B33.8570.22%0.83%0.26%12.82%
ECECL
77
Outperform
$75.71B36.3124.62%0.91%1.19%36.31%
RPRPM
72
Outperform
$14.83B22.9625.53%1.72%-0.61%15.06%
APAPD
64
Neutral
$63.04B41.1710.45%2.53%-1.09%-37.71%
PPPPG
64
Neutral
$25.41B18.8518.47%2.43%-7.67%-0.58%
DDDD
63
Neutral
$28.44B40.240.06%2.33%4.51%-121.68%
51
Neutral
$2.02B-1.12-21.36%3.65%2.87%-30.54%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ECL
Ecolab
266.93
30.07
12.70%
APD
Air Products and Chemicals
276.22
3.61
1.32%
PPG
PPG Industries
111.26
-14.21
-11.33%
RPM
RPM International
114.63
8.29
7.80%
SHW
Sherwin-Williams Company
357.88
68.32
23.59%
DD
DuPont de Nemours
67.41
-11.01
-14.04%

Ecolab Corporate Events

Private Placements and Financing
Ecolab Completes $500 Million Notes Issuance
Neutral
Jun 5, 2025

On June 5, 2025, Ecolab Inc. completed the issuance of $500 million in 4.300% Notes due 2028, following an underwriting agreement with Barclays Capital Inc., BofA Securities, Inc., and Santander US Capital Markets LLC. The proceeds from these Notes, which are part of a series of debt securities, are intended for general corporate purposes, potentially including debt repayment. The Notes, which bear interest payable semi-annually, are subject to redemption and repurchase conditions under certain circumstances, and the issuance is governed by covenants limiting certain financial activities.

The most recent analyst rating on (ECL) stock is a Hold with a $228.00 price target. To see the full list of analyst forecasts on Ecolab stock, see the ECL Stock Forecast page.

Executive/Board ChangesShareholder Meetings
Ecolab Appoints Marion K. Gross to Board
Positive
May 9, 2025

On May 7, 2025, Ecolab Inc. appointed Marion K. Gross to its board of directors, where she will also serve on the Compensation & Human Capital Management and Safety, Health & Environment Committees. Gross brings extensive experience from her tenure at McDonald’s, which is expected to enhance Ecolab’s strategic mission and growth plans. The company’s annual meeting on May 8, 2025, resulted in the election of 13 directors and approval of several proposals, including executive compensation and amendments to limit officer liability, reflecting a focus on strengthening governance and operational resilience.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.